Jump to:
loading...| Preferred Name |
naldemedine |
| Synonyms |
17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl- 1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide |
| ID |
http://purl.bioontology.org/ontology/MESH/C000620491 |
| altLabel |
17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl- 1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide Symproic S-297995 |
| cui |
C4507612 C4325235 C4325241 |
| Has mapping qualifier | |
| HM |
D009271/Q000031 |
| Inverse of RB |
0 03KSI6WLXH |
| LT |
TRD |
| Mapped to | |
| MDA |
20170615 |
| MeSH Frequency |
54 |
| MMR |
20220815 |
| notation |
C000620491 |
| prefLabel |
naldemedine |
| SC |
1 |
| Scope Statement |
a mu opioid receptor antagonist |
| SRC |
Drugs. 2017 May;77(8):923-7. |
| TERMUI |
T000927029 T000927027 T001123490 T000927028 |
| TH |
NLM (2017) FDA SRS (2017) USAN (19XX) NLM (2022) INN (19XX) |
| tui |
T109 T121 |
Create New Mapping